A closure for a sample tube comprises a reaction vessel. The reaction vessel comprises: at least one microfluidic mixing channel having an inlet and an outlet; at least one reaction chamber in fluid communication with the inlet and the outlet; an inlet chamber proximate the inlet of the at least one microfluidic mixing channel for introducing a portion of a sample solution from the sample tube into the at least one reaction chamber under hydrostatic pressure; and a diffusion-control feature for limiting egress of fluid from the outlet such that the portion of the sample solution introduced to the at least one reaction chamber is partitioned from the rest of the sample solution.

In biosciences and related fields, it can be useful to modify surfaces of apparatuses, devices, and materials that contact biomaterials such as biomolecules and biological micro-objects. Described herein are surface modifying and surface functionalizing reagents, preparation thereof, and methods for modifying surfaces to provide improved or altered performance with biomaterials.

The present disclosure relates to methods of purifying T cells, to T cells and T cell products produced by the methods, and use of the cells and products for therapy. In certain embodiments, the present disclosures provides a method of purifying T cells. The method comprises subjecting a medium comprising the T cells to inertial microfluidic fractionation and obtaining a fraction comprising purified T cells.

The present invention relates to a method for the sensitive identification of high-affinity complexes made of two ligands (2, 3, 4, 5, 6, 7) and one receptor (1). A large number of different ligands (2, 3, 4, 5, 6, 7) of a chemical library are hereby contacted with at least one receptor (1) in a solution. The ligands of the library have a single-strand DNA (8, 9) or RNA with a base length of 2 to 10 bases or alternatively more than 10 bases. In addition, the solution is incubated for a specific period of time and complexes made of two ligands (2, 3, 4, 5, 6, 7) and one receptor (1) are identified.

Methods and systems are provided for isolating fetal cells from a maternal blood supply in order to perform non-invasive prenatal testing. In one example, a system for non-invasive prenatal testing includes a substrate coated with a cell-capturing surface, the cell-capturing surface including an array of pillar-like structures, each pillar-like structure including a plurality of intersecting arms.

A plasmon resonance system, instrument, cartridge, and methods for analysis of analytes is disclosed. A PR system is provided that may include a DMF-LSPR cartridge that may support both digital microfluidic (DMF) capability and localized surface plasmon resonance (LSPR) capability for analysis of analytes. In some examples, the DMF portion of the DMF-LSPR cartridge may include an electrode arrangement for performing droplet operations, whereas the LSPR portion of the DMF-LSPR cartridge may include an LSPR sensor. In other examples, the LSPR portion of the DMF-LSPR cartridge may include an in-line reference channel, wherein the in-line reference channel may be a fluid channel including at least one functionalized LSPR sensor (or sample spot) and at least one non-functionalized LSPR sensor (or reference spot). Additionally, methods of using the PR system for analysis of analytes are provided.

Methods and systems are provided for isolating circulating tumor cells from a peripheral blood supply in order to diagnose early stage cancer and/or evaluate tumor status. In one example, a system for capturing circulating tumor cells includes a substrate having a cell-capturing region, the cell-capturing region having a curved, switchback-like shape and including an array of micropillar structures within the curved, switchback-like shape.

A method for extracting or enriching immune cells in a fluid sample, which contains immune and cancer cells and debris, includes the steps introducing the fluid sample into a first microfluidic device as two streams along two sidewalls thereof; applying a first power to the first microfluidic device to exert a first acoustic radiation pressure to produce a first output fluid having a higher relative fraction of the cancer cells than the fluid sample and a second output fluid having a lower relative fraction of the cancer cells than the fluid sample; introducing the second output fluid into a second microfluidic device as two streams along two sidewalls thereof; and applying a second power, which is higher than the first power, to the second microfluidic device to exert a second acoustic radiation pressure to produce a third output fluid having a higher relative fraction of the immune cells than the fluid sample.

Provided are methods and devices for evaluating coagulation, including the identification of a coagulation impairment such as a factor deficiency or the presence of a factor inhibitor. In various embodiments, the methods and devices measure coagulation of a sample in response to the addition of one or more coagulation factors, added at various concentrations to portions of the sample. Such coagulation measurements can be evaluated to accurately profile coagulation impairments of the sample. In additional various embodiments, point-of-care or bedside testing with a convenient, microfluidic device can be used by minimally trained personnel.

A method for separating biological entities in a fluid sample, which contains small, medium, and large biological entities, includes the steps introducing the fluid sample into a first microfluidic device as two streams along two sidewalls thereof; applying a first power to the first microfluidic device to exert a first acoustic radiation pressure to produce a first output fluid having a higher relative fraction of the large biological entities than the fluid sample and a second output fluid having a lower relative fraction of the large biological entities than the fluid sample; introducing the second output fluid into a second microfluidic device as two streams along two sidewalls thereof; and applying a second power, which is higher than the first power, to the second microfluidic device to exert a second acoustic radiation pressure to produce a third output fluid having a higher relative fraction of the medium biological entities than the fluid sample.